Skip to
  1. Homepage
  2. Rare diseases
  3. Search
Simple search

Simple search

*
(*) mandatory field





 

Other search option(s)

Familial infantile bilateral striatal necrosis

Orpha number ORPHA225154
Synonym(s) Familial IBSN
Familial infantile striatonigral degeneration
Familial infantile striatonigral necrosis
Prevalence <1 / 1 000 000
Inheritance Mitochondrial inheritance
Autosomal dominant
Autosomal recessive
Age of onset Infancy
Neonatal
ICD-10
  • G23.2
ICD-O -
OMIM
UMLS -
MeSH -
MedDRA -

Summary

Familial infantile bilateral striatal necrosis is the familial form of infantile bilateral striatal necrosis (IBSN; see this term), a syndrome of bilateral symmetric spongy degeneration of the caudate nucleaus, putamen and globus pallidus characterized by developmental regression, choreoathetosis and dystonia progressing to spastic quadriparesis.

The prevalence of familial IBSN has been estimated at less than 1/1,000,000.

The age of onset varies between 7 months and 15 months. Clinical features include choreoathetosis, dystonia, rigidity, spasticity, dysphagia, optic atrophy, intellectual deficit, developmental regression of motor and verbal skills, failure to thrive, myoclonus, quadriparesis, cerebellar ataxia and nystagmus. The disease has an insidious onset and a slowly progressive downhill course.

Autosomal recessive infantile striatonigral degeneration is caused by mutation in the NUP62 gene (19q13.33) and mitochondrial infantile striatonigral degeneration is caused by mutation in the ATP synthase-6 gene (MTATP6).

Diagnosis is based on clinical observation of choreoathetoid movements of the face, trunk and extremities and evidence of basal ganglia degeneration on CT and MRI images.

Differential diagnoses include Wilson's disease, acute disseminated encephalomyelitis, neurodegeneration with brain iron accumulation, Leigh disease, juvenile Huntington chorea, methylmalonic aciduria, guanidinoacetate methyltransferase deficiency, glutaric acidemia I (see these terms), carbon monoxide intoxication, small vessel arteritis and trauma.

Antenatal diagnosis and genetic counseling is offered to families of affected patients.

There is no standard therapy for familial IBSN. Treatment with oral biotin has been observed to slow disease progress initially.

Prognosis is usually poor with patients progressing to spastic quadriparesis followed by death, usually due to infection.

Expert reviewer(s)

  • Dr Rachel STRAUSSBERG

(*) Required fields.

Attention: Only comments seeking to improve the quality and accuracy of information on the Orphanet website are accepted. For all other comments, please send your remarks via contact us. Only comments written in English can be processed.


Captcha image
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.